Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CASP2 | P42575 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 3/20 | 0.47 |
| ▸ | ACHE | P22303 | 2/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7055391 | 1.00 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| Hydrochloric Acid SCHEMBL1032458 | 1.00 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL6397609 | 1.00 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| Hydrochloric Acid SCHEMBL346360 | 1.00 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| Hydrochloric Acid SCHEMBL9132796 | 1.00 | TSHR (0.56) | TSHRPOLBAPEX1HTTTDP1 | |
| Bromide SCHEMBL7058976 | 0.98 | TSHR (0.54) | TSHRPOLBAPEX1HTTTDP1 | |
| Bromide SCHEMBL7056467 | 0.98 | TSHR (0.54) | TSHRPOLBAPEX1HTTTDP1 | |
| Bromide SCHEMBL31748172 | 0.98 | TSHR (0.54) | TSHRPOLBAPEX1HTTTDP1 | |
| Bromide SCHEMBL345541 | 0.98 | TSHR (0.54) | TSHRPOLBAPEX1HTTTDP1 | |
| Bromide SCHEMBL31748176 | 0.98 | TSHR (0.54) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230055449-A1 | FUNCTIONAL SURFACES | ORTHOBOND CORP (US) | 2023-02-23 | — | — | US | claimed |
| EP-3525776-B1 | SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS | ORTHOBOND CORP (US) | 2022-01-26 | — | — | EP | claimed |
| CN-110312507-B | Surfaces with oligomeric or polymeric antimicrobial agents | 奥索邦德公司 | 2021-11-23 | — | — | CN | claimed |
| US-20210352903-A1 | FUNCTIONAL SURFACES | ORTHOBOND CORP (US) | 2021-11-18 | — | — | US | claimed |
| US-11154061-B2 | Functional surfaces | Orthobond Corporation (US) | 2021-10-26 | — | — | US | claimed |
| US-10390533-B2 | Surfaces with oligomeric or polymeric antimicrobials | Orthobond Corporation (US) | 2019-08-27 | — | — | US | claimed |
| EP-3525776-A1 | SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS | Orthobond Corporation (US) | 2019-08-21 | — | — | EP | claimed |
| WO-2018075457-A1 | SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS | Orthobond Corporation (US) | 2018-04-26 | — | — | WO | claimed |
| US-20180103642-A1 | Surfaces with Oligomeric or Polymeric Antimicrobials | Orthobond Corporation | 2018-04-19 | — | — | US | claimed |
| US-20180103643-A1 | Functional Surfaces | Orthobond Corporation | 2018-04-19 | — | — | US | claimed |
| US-6355704-B1 | BACTERICIDE PRIMERS; BONDING TO TEETH | KURARAY CO., LTD. (JP) | 2002-03-12 | — | — | US | claimed |
| US-20230055449-A1 | FUNCTIONAL SURFACES | ORTHOBOND CORP (US) | 2023-02-23 | — | — | US | disclosed |
| WO-2022182713-A1 | METHODS OF PHOTOGRAFTING TO SURFACE METAL OXIDES | Orthobond Corporation (US) | 2022-09-01 | — | — | WO | disclosed |
| US-20220266296-A1 | Methods of Photografting to Surface Metal Oxides | Orthobond Corporation | 2022-08-25 | — | — | US | disclosed |
| EP-3525776-B1 | SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS | ORTHOBOND CORP (US) | 2022-01-26 | — | — | EP | disclosed |
| EP-0980682-B1 | Bonding compositions for dental use | KURARAY CO (JP) | 2003-11-05 | — | — | EP | disclosed |
| CN-1386132-A | antibacterial composition | KURARAY CO (JP) | 2002-12-18 | — | — | CN | disclosed |
| US-20020035169-A1 | Bonding compositions for dental use | KURARAY CO., LTD (JP) | 2002-03-21 | — | — | US | disclosed |
| US-6355704-B1 | BACTERICIDE PRIMERS; BONDING TO TEETH | KURARAY CO., LTD. (JP) | 2002-03-12 | — | — | US | disclosed |
| EP-0980682-A1 | Bonding compositions for dental use | KURARAY CO., LTD. (JP) | 2000-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035169-A1 | Bonding compositions for dental use | PTK2, DEK, POLK | TSHR 4726/4885POLB 39/4885APEX1 586/4885 |
| US-20180103642-A1 | Surfaces with Oligomeric or Polymeric Antimicrobials | PICALM, NONO, LPO | TSHR 1455/4885POLB 1274/4885APEX1 279/4885 |
| US-20230055449-A1 | FUNCTIONAL SURFACES | LPO, SELP, SIGLEC7 | TSHR 2514/4885POLB 2915/4885APEX1 241/4885 |
| US-11154061-B2 | Functional surfaces | LPO, SELP, SIGLEC7 | TSHR 2514/4885POLB 2915/4885APEX1 241/4885 |
| US-20210352903-A1 | FUNCTIONAL SURFACES | LPO, SELP, SIGLEC7 | TSHR 2514/4885POLB 2915/4885APEX1 241/4885 |
| US-10390533-B2 | Surfaces with oligomeric or polymeric antimicrobials | PICALM, NONO, LPO | TSHR 1455/4885POLB 1274/4885APEX1 279/4885 |
| US-20180103643-A1 | Functional Surfaces | LPO, SELP, SIGLEC7 | TSHR 2514/4885POLB 2915/4885APEX1 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.